Nuo Therapeutics, Inc. (AURX) Form 8-K — Jun 2, 2026
Nuo Therapeutics entered into an Amended and Restated Loan and Security Agreement on May 29, 2026, securing $675,000 in interim funding and increasing its total debt commitment to $2.0 million. The facility includes a $1.0 million initial tranche already funded, the new $675,000 interim tranche, and a $325,000 second tranche available upon request by September 30, 2026. The debt carries a 12% annual interest rate, payable in warrants rather than cash, and matures on December 31, 2028. Principal repayments begin in quarterly installments starting March 31, 2027.
Key figures
- Total Debt
- 2000000
- Debt Amount
- 675000
- Interest Rate
- 12
- Maturity Date
- 2028-12-31
- Offering Price
- 1.5
- Shares Offered
- 120125
- Initial funding amount
- 1000000
- Prepayment fee mandatory
- 2.75%
- Prepayment fee voluntary
- 1.5%
- Total warrants immediate
- 120125
- Second funding commitment
- 325000
- Total warrants interest max
- 303667
- Total warrants vesting prepayment
- 36665
- Total warrants vesting second funding
- 56875
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.